Patent Assignment
Reel/Frame 031694/0287
Change of Name
Recorded: 2013-11-21
Pages: 2
Assignor
CEPHALON AUSTRALIA PTY LTD
Executed: 2013-08-30
Assignee
TEVA PHARMACEUTICALS AUSTRALIA PTY LTD
LEVEL 2, 37 EPPING ROAD, MACQUARIE PARK, NEW SOUTH WALES, 2113, AUSTRALIA
Covered Properties
(2)
Monoclonal Antibody SC104 and Derivative Thereof Specifically Binding to a Sialyltetraosyl Carbohydrate as a Potential Anti-Tumor Therapeutic Agent
Monoclonal Antibody SC104 and Derivative Thereof Specifically Binding to a Sialyltetraosyl Carbohydrate as a Potential Anti-Tumor Therapeutic Agent
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 13, 2007
From: DURRANT, LINDA GILLIAN; PARSONS, TINA
To: SCANCELL LIMITED
Reel/Frame 019683/0206 →
Assignment of Assignor's Interest
Apr 4, 2008
From: SCANCELL LIMITED
To: ARANA THERAPEUTICS LIMITED
Reel/Frame 020758/0837 →
Change of Name
Aug 19, 2010
From: ARANA THERAPEUTICS PTY LTD
To: CEPHALON AUSTRALIA PTY LTD
Reel/Frame 024860/0611 →
Conversion to a Proprietary Company
Aug 19, 2010
From: ARANA THERAPEUTICS LIMITED
To: ARANA THERAPEUTICS PTY LTD
Reel/Frame 024860/0617 →